DK1156795T3 - Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens - Google Patents
Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistensInfo
- Publication number
- DK1156795T3 DK1156795T3 DK99933301T DK99933301T DK1156795T3 DK 1156795 T3 DK1156795 T3 DK 1156795T3 DK 99933301 T DK99933301 T DK 99933301T DK 99933301 T DK99933301 T DK 99933301T DK 1156795 T3 DK1156795 T3 DK 1156795T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- succinic acid
- insulin resistance
- salts
- treating insulin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/RU1999/000055 WO2000051594A1 (en) | 1999-03-01 | 1999-03-01 | Use of succinic acid or salts thereof and method of treating insulin resistance |
| EP99933301A EP1156795B1 (en) | 1999-03-01 | 1999-03-01 | Use of succinic acid or salts thereof and method of treating insulin resistance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1156795T3 true DK1156795T3 (da) | 2004-11-01 |
Family
ID=20130328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99933301T DK1156795T3 (da) | 1999-03-01 | 1999-03-01 | Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6521665B1 (da) |
| EP (1) | EP1156795B1 (da) |
| AT (1) | ATE268170T1 (da) |
| AU (1) | AU4937499A (da) |
| CA (1) | CA2366073A1 (da) |
| DE (1) | DE69917809T2 (da) |
| DK (1) | DK1156795T3 (da) |
| ES (1) | ES2222717T3 (da) |
| PT (1) | PT1156795E (da) |
| WO (1) | WO2000051594A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2404864A1 (en) * | 2000-04-10 | 2001-10-18 | Tatiyana Jurievna Ukhanova | Synergistic compositions containing choline base and succinic acid for insulin resistance and diabetes |
| CN101815515A (zh) * | 2007-08-02 | 2010-08-25 | 布达生物制药有限公司 | 含有琥珀酸的鼻内用药物组合物 |
| JP5460183B2 (ja) * | 2009-08-28 | 2014-04-02 | パナソニック株式会社 | 分析用試薬および分析用デバイス |
| WO2011007514A1 (ja) * | 2009-07-15 | 2011-01-20 | パナソニック株式会社 | 分析用試薬およびこれを担持した分析用デバイス |
| KR20210024056A (ko) * | 2018-06-22 | 2021-03-04 | 엔진 바이오사이언스 리미티드 | 혈액 장애 치료를 위한 숙신산 및 유도체 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61171417A (ja) * | 1985-01-23 | 1986-08-02 | Wakunaga Seiyaku Kk | 抗糖尿病剤 |
| JP3581157B2 (ja) * | 1992-08-19 | 2004-10-27 | 株式会社ミツカングループ本社 | 低耐糖能者用食品 |
-
1999
- 1999-03-01 WO PCT/RU1999/000055 patent/WO2000051594A1/en active IP Right Grant
- 1999-03-01 CA CA002366073A patent/CA2366073A1/en not_active Abandoned
- 1999-03-01 EP EP99933301A patent/EP1156795B1/en not_active Expired - Lifetime
- 1999-03-01 US US09/914,499 patent/US6521665B1/en not_active Expired - Fee Related
- 1999-03-01 AT AT99933301T patent/ATE268170T1/de not_active IP Right Cessation
- 1999-03-01 DK DK99933301T patent/DK1156795T3/da active
- 1999-03-01 ES ES99933301T patent/ES2222717T3/es not_active Expired - Lifetime
- 1999-03-01 DE DE69917809T patent/DE69917809T2/de not_active Expired - Lifetime
- 1999-03-01 AU AU49374/99A patent/AU4937499A/en not_active Abandoned
- 1999-03-01 PT PT99933301T patent/PT1156795E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000051594A1 (en) | 2000-09-08 |
| ATE268170T1 (de) | 2004-06-15 |
| PT1156795E (pt) | 2004-09-30 |
| EP1156795B1 (en) | 2004-06-02 |
| DE69917809T2 (de) | 2004-11-04 |
| DE69917809D1 (de) | 2004-07-08 |
| US6521665B1 (en) | 2003-02-18 |
| EP1156795A1 (en) | 2001-11-28 |
| AU4937499A (en) | 2000-09-21 |
| ES2222717T3 (es) | 2005-02-01 |
| CA2366073A1 (en) | 2000-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1539166T3 (da) | Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme | |
| EP1140840A4 (en) | -G (V) -CARBOXYARYL SUBSTITUTED DIPHENYL UREASINE AS RAF KINASE INHIBITORS | |
| DK1202736T3 (da) | Nikotin i terapeutisk angiogenese og vasculogenese | |
| EA200401284A1 (ru) | Замещённые бензазолы и их применение в качестве ингибиторов киназы raf | |
| DK1187603T3 (da) | Kombinationsterapi tl at bevirke vægttab og at behandle obesitet | |
| BR9814923A (pt) | Método para tratamento de doença de alzheimer | |
| DK1280541T4 (da) | Anvendelse af hydrogenotrofe, acetogene stammer til forebyggelse eller behandling af fordøjelsesforstyrrelser | |
| NO992705L (no) | 3-pyridylenantiomere og deres anvendelse som analgetika | |
| DK0998287T3 (da) | Anvendelse af levobupivacain | |
| ATE364595T1 (de) | Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika | |
| DK1228028T3 (da) | Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser | |
| PT932613E (pt) | Expressao de bloqueio de factoes de virulencia em s. aureus | |
| ATE249835T1 (de) | Immunoregulator | |
| EE05241B1 (et) | Distamtsiini a-halogenoakrlolderivaadi kasutamine | |
| DK1156795T3 (da) | Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens | |
| DK0799618T3 (da) | Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer | |
| BR9814867A (pt) | Método para tratar discinesias relacionadas a doenças ou induzidas por drogas | |
| DK1073436T3 (da) | Forbedret fremgangsmåde til udryddelse af helicobacter pylori | |
| NO20042138L (no) | Forbindelser og fremgangsmate for behandling av hyperaktiv blaere | |
| DE60008590D1 (de) | Zusammensetzungen von adenosin a1 agonisten und cox2-hemmern | |
| CY1109771T1 (el) | Η χρηση της φορμοτερολης στην προφυλακτικη και/ή θεραπευτικη αντιμετωπιση της μυικης απωλειας και/ή του καχεκτικου συνδρομου τα οποια συνδεονται με τις καταβολικες συνθηκες ορισμενων παθησεων. οπως ο καρκινος, to aids, οι μολυνσεις, ο διαβητης και αλλες | |
| SE9904289D0 (sv) | Method and camposition for the treatment of adenovairal ocular infections | |
| DK1227826T3 (da) | Sammensætninger omfattende et ekstrakt af Perna canaliculus, methylsulfonylmethan og glucosamid samt anvendelsen heraf | |
| BRPI0408984A (pt) | método para tratar uma condição de doença mediada por células neutrofìlicas em um paciente, e, uso de um composto de ligação de histamina | |
| ITRM20020308A1 (it) | Apparecchiatura per trattamenti terapeutici, e relativo metodo. |